NCT01405105View on ClinicalTrials.gov

Exacerbating Factors in Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

134

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Ulcerative ColitisCrohn's Disease
Trial Locations (1)

75216

Dallas VA Medical Center, Dallas

Sponsors
All Listed Sponsors
collaborator

Centocor Ortho Biotech Services, L.L.C.

INDUSTRY

lead

Dallas VA Medical Center

FED

NCT01405105 - Exacerbating Factors in Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter